Assay Kits

Assay kits are used to carry out analyses in a broad scope of applications including the study of targets such as drugs, molecules, disease pathways, chemical elements or compounds, and organisms. They are a routine procedure in the modern pharmaceutical, medical and forensic world as well as research and university laboratories around the globe. Assay kits come with all the necessary reagents, instructions and protocols for fast and efficient processing, allowing for repeatable results.
CompanyIBL-AmericaIBL-AmericaIBL-AmericaIBL-AmericaIBL-America
ItemComplement Factor P (Properdin) Quantitative AssayAmyloid Beta (1-40) (FL) ELISA AssayAnti-Trastuzumab (Herceptin®) ELISAInsulin-like Growth Factor-Binding Protein-3 (IGFBP-3) ELISAPMN Elastase ELISA Assay
Citations
(14)
Catalog NumberCOMPL FPQ RUO27718TM09015E03AIB79187
PriceSupplier PageSupplier PageSupplier PageSupplier PageSupplier Page
DescriptionThe Wieslab® Complement Factor P Quantitative Assay (COMPL FPQ) is an enzyme immunoassay (ELISA) for the quantitation of the amount of human Factor P in test samples. For research use only, not for use in diagnostic procedures.Solid phase sandwich ELISA for the determination of human A ß (1-40) (FL) in EDTA-plasma, cerebrospinal fluids, serum, cell culture media or the extract from brain tissue. For research use only, not for use in diagnostic procedures.Enzyme immunoassay (ELISA) test kit for the determination of free antibodies directed against the drug Trastuzumab (Herceptin®, Herclon®) in serum and plasma. For research use only, not for use in diagnostic procedures.Enzyme immunoassay (ELISA) for the determination of IGFBP-3 in human serum, plasma (heparin), or cerebrospinal fluid. For research use only, not for use in diagnostic procedures.Solid phase enzyme immunometric assay (ELISA) for the determination of PMN elastase in EDTA or citrated plasma, exudate, bronchoalveolar lavage fluid, cerebrospinal fluid and seminal plasma. For research use only, not for use in diagnostic procedures.
Detection TargetComplement Factor P (Properdin)APP-Beta-CTFRanibizumab (Lucentis®) (mAb-based)Complement System ScreenHE4
Sample TypeSerum, Blood PlasmaCell LysateAqueous humourSerumSerum
MethodEnzyme-Linked Immunosorbent Assay (ELISA)Enzyme-Linked Immunosorbent Assay (ELISA)Enzyme-Linked Immunosorbent Assay (ELISA)Enzyme-Linked Immunosorbent Assay (ELISA)Enzyme-Linked Immunosorbent Assay (ELISA)
Detection Range0 / 12.5 - 200 ng/mL1.56 to 100 pg/mL0 / 30 - 1000 ng/mL0.4 to 30.0 ng/mL15.6 to 1000 ng/mL
Sensitivity93.55% (95% confidence interval: 89.41% - 96.43%)0.02 pmol/L0.33 ng/mLInquire< 25 pM.
Assay Time60 min. (RT) + 30 min. (RT) + 30 min. (RT) = 2 hours incubation time.Overnight + 1 hr 30 mins (incubation)2 hours, 15 min. total incubation time.2 hrs 30 mins (incubation)2 hrs 20 mins (incubation)
Get QuoteSupplier PageSupplier PageSupplier PageSupplier PageSupplier Page

Articles